Trial updateRetina
A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
Recruiting. Phase 1. Registered enrolment: 30. Astellas Institute for Regenerative Medicine
Why it matters
Track this study through NCT07734064. No results are posted in this registry record.
The study at a glance
- Registry status
- Recruiting
- Phase
- Phase 1
- Registered enrolment
- 30
- Results posted
- No
- Sponsor
- Astellas Institute for Regenerative Medicine
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.